Telma-Mct 25/12.5MG Tab

Tablet

Treatment of hypertension (high blood pressure), especially when single-drug therapy is not sufficient; helps reduce risk of cardiovascular complications associated with uncontrolled BP.

Telmisartan is an angiotensin II receptor blocker (ARB) that relaxes blood vessels by blocking angiotensin II, lowering blood pressure. Chlorthalidone is a thiazide-like diuretic that increases salt and water excretion, reducing blood volume and blood pressure.

Take by mouth as prescribed, usually once daily at the same time each day. Can be taken with or without food. Swallow tablet whole with water; do not stop abruptly without medical advice.

Dizziness, lightheadedness, low blood pressure, increased urination, dehydration, headache, fatigue, nausea, electrolyte imbalance (low potassium/low sodium), increased uric acid, increased blood sugar

Monitor blood pressure, kidney function and electrolytes (especially potassium, sodium). Risk of dehydration and hypotension, especially in elderly or with vomiting/diarrhea. Use caution in kidney or liver impairment. May worsen gout (raises uric acid) and affect blood glucose. Avoid potassium supplements/salt substitutes unless advised. Not recommended in pregnancy; can harm the fetus. Seek help for severe dizziness, fainting, reduced urination, swelling of face/lips, or breathing difficulty.

Other antihypertensives (additive hypotension), NSAIDs (reduced effect and kidney risk), lithium (toxicity risk), potassium supplements/potassium-sparing diuretics (hyperkalemia risk), ACE inhibitors or aliskiren (increased kidney risk/hyperkalemia; avoid in diabetes with aliskiren), corticosteroids (electrolyte imbalance), digoxin (electrolyte-related toxicity risk)

Store below 30°C in a dry place, protected from moisture and light. Keep in original blister pack and out of reach of children.

Telma-MCT 40/12.5 Tablet, Telmikind-CT 40/12.5 Tablet, Telsar-CT 40/12.5 Tablet, Cresar-CH 40/12.5 Tablet, Telvas-CT 40/12.5 Tablet